154 related articles for article (PubMed ID: 37340108)
21. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
22. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
Zhao H; Zhang N; Ho V; Ding M; He W; Niu J; Yang M; Du XL; Zorzi D; Chavez-MacGregor M; Giordano SH
Cancer; 2018 Feb; 124(4):679-687. PubMed ID: 29140558
[TBL] [Abstract][Full Text] [Related]
23. Improved overall survival is still observed in patients receiving delayed adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Turner MC; Masoud SJ; Cerullo M; Adam MA; Shah KN; Blazer DG; Abbruzzese JL; Zani S
HPB (Oxford); 2020 Nov; 22(11):1542-1548. PubMed ID: 32299656
[TBL] [Abstract][Full Text] [Related]
24. Delivery of adjuvant chemotherapy among stage III colon cancer patients at a public versus private hospital in New York City.
Lin D; Goldberg JD; Hochman T; Levinson BA; Khan M; Newman E; Leichman LP; Gold HT
Cancer Causes Control; 2018 Feb; 29(2):253-260. PubMed ID: 29250702
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy in stage 1 colon cancer: Patient characteristics and survival analysis from the national cancer database.
Hsu AT; Wolf JH; D'Adamo CR; Felton J; Paul S; Kumar P; Mavanur AA
Surg Oncol; 2024 Jun; 54():102075. PubMed ID: 38636304
[TBL] [Abstract][Full Text] [Related]
26. National Quality Forum Colon Cancer Quality Metric Performance: How Are Hospitals Measuring Up?
Mason MC; Chang GJ; Petersen LA; Sada YH; Tran Cao HS; Chai C; Berger DH; Massarweh NN
Ann Surg; 2017 Dec; 266(6):1013-1020. PubMed ID: 27617852
[TBL] [Abstract][Full Text] [Related]
27. Assessment of adjuvant chemotherapy benefits after complete mesocolic excision in patients with colon cancer: Reanalysis of data from the ESCME trial.
Wang C; Gan L; Shen Z; Jiang K; Gao Z; Ye Y
Colorectal Dis; 2022 Nov; 24(11):1335-1343. PubMed ID: 35723932
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant chemotherapy is associated with improved overall survival in select patients with Stage II colon cancer: A National Cancer Database analysis.
Grant RRC; Khan TM; Gregory SN; Coakley BA; Hernandez JM; Davis JL; Blakely AM
J Surg Oncol; 2022 Sep; 126(4):748-756. PubMed ID: 35698854
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans.
Aspinall SL; Good CB; Zhao X; Cunningham FE; Heron BB; Geraci M; Passero V; Stone RA; Smith KJ; Rogers R; Shields J; Sartore M; Boyle DP; Giberti S; Szymanski J; Smith D; Ha A; Sessions J; Depcinski S; Fishco S; Molina I; Lepir T; Jean C; Cruz-Diaz L; Motta J; Calderon-Vargas R; Maland J; Keefe S; Tague M; Leone A; Glovack B; Kaplan B; Cosgriff S; Kaster L; Tonnu-Mihara I; Nguyen K; Carmichael J; Clifford L; Lu K; Chatta G
BMC Cancer; 2015 Feb; 15():62. PubMed ID: 25884851
[TBL] [Abstract][Full Text] [Related]
30. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
[TBL] [Abstract][Full Text] [Related]
31. Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer.
Khalil L; Gao X; Switchenko JM; Alese OB; Akce M; Wu C; Diab M; El-Rayes BF; Shaib WL
Oncologist; 2022 Sep; 27(9):740-750. PubMed ID: 35648074
[TBL] [Abstract][Full Text] [Related]
32. Is There a Role for Neoadjuvant Systemic Therapy for cT4bM0 Colon Cancer? A Propensity Score-Matched Analysis of the National Cancer Database.
Kamel MK; Shchatsko A; Keane CA; Serpa E; Al-Qudah G; Rahouma M; Nituica C; Blebea J; Marar O
Dis Colon Rectum; 2023 Nov; 66(11):1435-1448. PubMed ID: 36876973
[TBL] [Abstract][Full Text] [Related]
33. Effect of the duration of the capecitabine regimen following colon cancer surgery in an elderly population: a retrospective cohort study.
Chen W; Dong H; Wang G; Chen J; Wang W
World J Surg Oncol; 2021 Aug; 19(1):238. PubMed ID: 34380513
[TBL] [Abstract][Full Text] [Related]
34. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
[TBL] [Abstract][Full Text] [Related]
35. Omission of Adjuvant Chemotherapy Is Associated With Increased Mortality in Patients With T3N0 Colon Cancer With Inadequate Lymph Node Harvest.
Wells KO; Hawkins AT; Krishnamurthy DM; Dharmarajan S; Glasgow SC; Hunt SR; Mutch MG; Wise P; Silviera ML
Dis Colon Rectum; 2017 Jan; 60(1):15-21. PubMed ID: 27926553
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
[TBL] [Abstract][Full Text] [Related]
37. Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
Meyerhardt JA; Shi Q; Fuchs CS; Meyer J; Niedzwiecki D; Zemla T; Kumthekar P; Guthrie KA; Couture F; Kuebler P; Bendell JC; Kumar P; Lewis D; Tan B; Bertagnolli M; Grothey A; Hochster HS; Goldberg RM; Venook A; Blanke C; O'Reilly EM; Shields AF
JAMA; 2021 Apr; 325(13):1277-1286. PubMed ID: 33821899
[TBL] [Abstract][Full Text] [Related]
38. Factors Associated with the Lack of Adjuvant Chemotherapy Following Curative Surgery for Stage II and III Colon Cancer: A Korean National Cohort Study.
Ha GS; Kim YW; Choi EH; Kim IY
Anticancer Res; 2017 Feb; 37(2):915-922. PubMed ID: 28179352
[TBL] [Abstract][Full Text] [Related]
39. Timeliness of adjuvant chemotherapy for stage III adenocarcinoma of the colon: a measure of quality of care.
Yu S; Shabihkhani M; Yang D; Thara E; Senagore A; Lenz HJ; Sadeghi S; Barzi A
Clin Colorectal Cancer; 2013 Dec; 12(4):275-9. PubMed ID: 24188686
[TBL] [Abstract][Full Text] [Related]
40. Analysis of delay in adjuvant chemotherapy in locally advanced rectal cancer.
Farzaneh CA; Pigazzi A; Duong WQ; Carmichael JC; Stamos MJ; Dekhordi-Vakil F; Dayyani F; Zell JA; Jafari MD
Tech Coloproctol; 2023 Jan; 27(1):35-42. PubMed ID: 36042105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
